These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 24527745

  • 1. Improving the classification of migraine subtypes: an empirical approach based on factor mixture models in the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB, Serrano D, Pavlovic JM, Manack AN, Reed ML, Turkel CC, Buse DC.
    Headache; 2014 May; 54(5):830-49. PubMed ID: 24527745
    [Abstract] [Full Text] [Related]

  • 2. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study.
    Buse DC, Manack AN, Fanning KM, Serrano D, Reed ML, Turkel CC, Lipton RB.
    Headache; 2012 May; 52(10):1456-70. PubMed ID: 22830411
    [Abstract] [Full Text] [Related]

  • 3. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study.
    Buse D, Manack A, Serrano D, Reed M, Varon S, Turkel C, Lipton R.
    Headache; 2012 Jan; 52(1):3-17. PubMed ID: 22106869
    [Abstract] [Full Text] [Related]

  • 4. Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
    Buse DC, Serrano D, Reed ML, Kori SH, Cunanan CM, Adams AM, Lipton RB.
    Headache; 2015 Jun; 55(6):825-39. PubMed ID: 25881857
    [Abstract] [Full Text] [Related]

  • 5. Examination of unmet treatment needs among persons with episodic migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB, Buse DC, Serrano D, Holland S, Reed ML.
    Headache; 2013 Sep; 53(8):1300-11. PubMed ID: 23879870
    [Abstract] [Full Text] [Related]

  • 6. Acute treatment optimization in episodic and chronic migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study.
    Serrano D, Buse DC, Manack Adams A, Reed ML, Lipton RB.
    Headache; 2015 Apr; 55(4):502-18. PubMed ID: 25881676
    [Abstract] [Full Text] [Related]

  • 7. Persistent frequent nausea is associated with progression to chronic migraine: AMPP study results.
    Reed ML, Fanning KM, Serrano D, Buse DC, Lipton RB.
    Headache; 2015 Jan; 55(1):76-87. PubMed ID: 25250833
    [Abstract] [Full Text] [Related]

  • 8. Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) Study.
    Buse DC, Loder EW, Gorman JA, Stewart WF, Reed ML, Fanning KM, Serrano D, Lipton RB.
    Headache; 2013 Sep; 53(8):1278-99. PubMed ID: 23808666
    [Abstract] [Full Text] [Related]

  • 9. Demographics, Headache Features, and Comorbidity Profiles in Relation to Headache Frequency in People With Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study.
    Buse DC, Reed ML, Fanning KM, Bostic RC, Lipton RB.
    Headache; 2020 Oct 14. PubMed ID: 33090481
    [Abstract] [Full Text] [Related]

  • 10. A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache-Related Disability.
    Lipton RB, Manack Adams A, Buse DC, Fanning KM, Reed ML.
    Headache; 2016 Sep 14; 56(8):1280-9. PubMed ID: 27349336
    [Abstract] [Full Text] [Related]

  • 11. Asthma is a risk factor for new onset chronic migraine: Results from the American migraine prevalence and prevention study.
    Martin VT, Fanning KM, Serrano D, Buse DC, Reed ML, Lipton RB.
    Headache; 2016 Jan 14; 56(1):118-31. PubMed ID: 26581563
    [Abstract] [Full Text] [Related]

  • 12. Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine.
    Silberstein SD, Lee L, Gandhi K, Fitzgerald T, Bell J, Cohen JM.
    Headache; 2018 Nov 14; 58(10):1579-1592. PubMed ID: 30375650
    [Abstract] [Full Text] [Related]

  • 13. Predicting Inadequate Response to Acute Migraine Medication: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB, Munjal S, Buse DC, Fanning KM, Bennett A, Reed ML.
    Headache; 2016 Nov 14; 56(10):1635-1648. PubMed ID: 27731896
    [Abstract] [Full Text] [Related]

  • 14. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Munakata J, Hazard E, Serrano D, Klingman D, Rupnow MF, Tierce J, Reed M, Lipton RB.
    Headache; 2009 Apr 14; 49(4):498-508. PubMed ID: 19245386
    [Abstract] [Full Text] [Related]

  • 15. Impact of NSAID and Triptan use on developing chronic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study.
    Lipton RB, Serrano D, Nicholson RA, Buse DC, Runken MC, Reed ML.
    Headache; 2013 Apr 14; 53(10):1548-63. PubMed ID: 23992516
    [Abstract] [Full Text] [Related]

  • 16. Opioid use and dependence among persons with migraine: results of the AMPP study.
    Buse DC, Pearlman SH, Reed ML, Serrano D, Ng-Mak DS, Lipton RB.
    Headache; 2012 Jan 14; 52(1):18-36. PubMed ID: 22268775
    [Abstract] [Full Text] [Related]

  • 17. When does chronic migraine strike? A clinical comparison of migraine according to the headache days suffered per month.
    Torres-Ferrús M, Quintana M, Fernandez-Morales J, Alvarez-Sabin J, Pozo-Rosich P.
    Cephalalgia; 2017 Feb 14; 37(2):104-113. PubMed ID: 26961321
    [Abstract] [Full Text] [Related]

  • 18. The International Classification of Headache Disorders revised criteria for chronic migraine—field testing in a headache specialty clinic.
    Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB.
    Cephalalgia; 2007 Mar 14; 27(3):230-4. PubMed ID: 17263770
    [Abstract] [Full Text] [Related]

  • 19. Tracing transformation: chronic migraine classification, progression, and epidemiology.
    Lipton RB.
    Neurology; 2009 Feb 03; 72(5 Suppl):S3-7. PubMed ID: 19188564
    [Abstract] [Full Text] [Related]

  • 20. Effects of switching acute treatment on disability in migraine patients using triptans.
    Serrano D, Buse DC, Kori SH, Papapetropoulos S, Cunanan CM, Manack AN, Reed ML, Lipton RB.
    Headache; 2013 Oct 03; 53(9):1415-29. PubMed ID: 23808937
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.